Zobrazeno 1 - 10
of 41
pro vyhledávání: '"U, Fantoni"'
Autor:
A. Scarda, M. Confalonieri, C. Baghiris, S. Binato, R. Mazzarotto, A. Palamidese, R. Zuin, U. Fantoni
Publikováno v:
Monaldi Archives for Chest Disease, Vol 67, Iss 3 (2016)
Background and Aim. Out-patient high-dose-rate endobronchial brachytherapy (HDREB) is a possible option in the palliation of symptoms in patients with advanced lung cancer, but literature data is limited and the technique is still under development i
Externí odkaz:
https://doaj.org/article/d93910dddc2b4ce4aa61077252e175de
Autor:
S. Binato, R. Zuin, M. Confalonieri, C. Baghiris, R. Mazzarotto, U. Fantoni, A. Palamidese, A. Scarda
Publikováno v:
Monaldi Archives for Chest Disease, Vol 67, Iss 3 (2016)
Scopus-Elsevier
Scopus-Elsevier
Background and Aim. Out-patient high-dose-rate endobronchial brachytherapy (HDREB) is a possible option in the palliation of symptoms in patients with advanced lung cancer, but literature data is limited and the technique is still under development i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55b69cbbf1c328ecb982d251b74dfe2
https://www.monaldi-archives.org/index.php/macd/article/view/483
https://www.monaldi-archives.org/index.php/macd/article/view/483
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S232-S233
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c509373c4097b5b123d1cb17efd63f35
https://doi.org/10.1016/j.healun.2016.01.661
https://doi.org/10.1016/j.healun.2016.01.661
Autor:
Federico Rea, Marco Schiavon, Andrea Zuin, U. Fantoni, F. De Filippis, Samuele Nicotra, G. Marulli, F. Di Chiara
Secondary pneumothorax represents a challenging problem in patients with chronic obstructive pulmonary disease, due to their compromised health status. In this case, an endobronchial one-way valve was inserted in the left lower lobe by flexible bronc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085728987a30d20b895cc0e818daa4ea
http://hdl.handle.net/11577/2485198
http://hdl.handle.net/11577/2485198
Autor:
A. Iop, Samuela Binato, E. Colombrino, U. Fantoni, S. Cingarlini, Cosimo Sacco, Giuseppe Cartei, A. Palamidese, Simona Scalone, Renato Ceravolo, Alessandra Bearz
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17
Chemotherapy of non-small-cell lung cancer (NSCLC) has been improved by the use of cis-platin (P) and the pyrimidine antimetabolite gemcitabine (G) (2',2'-difluorodeoxycytidine). GP regimens currently used in Italy for NSCLC were and are mainly based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1e7c6547f9317c2ad376e37cc4cb59
https://pubmed.ncbi.nlm.nih.gov/16807462
https://pubmed.ncbi.nlm.nih.gov/16807462
Publikováno v:
The Journal of Heart and Lung Transplantation. 29:S79-S80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd05ca9ff01a52d96619a1715f8d42c
https://doi.org/10.1016/j.healun.2009.11.242
https://doi.org/10.1016/j.healun.2009.11.242
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 14(4)
The aim of the study is to analyse long-term results of patients with small cell lung cancer (SCLC) treated at the same institution according to a prospective study including surgery, chemotherapy, and radiotherapy.From 1981 to 1995, 104 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a57c0204576438ef2751a5230154800d
https://pubmed.ncbi.nlm.nih.gov/9845145
https://pubmed.ncbi.nlm.nih.gov/9845145
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Penetration of aztreonam into pleural exudate following rapid intravenous bolus or constant infusion
Publikováno v:
Chemotherapy. 36(5)
A study on the effects of the mode of administration on aztreonam (AZ) concentrations in pleural fluid was performed in human subjects. The same dose of AZ was given as an intravenous bolus injection to one group and as a drip infusion to another gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1897841ce8af85e9cac4d0d0485f10
https://pubmed.ncbi.nlm.nih.gov/2209165
https://pubmed.ncbi.nlm.nih.gov/2209165
Autor:
Cosimo Sacco, Giuseppe Cartei, E. Colombrino, U. Fantoni, R. Ceravolo, A. Palamidese, S. Cingarlini, Simona Scalone, S. Binato, A. Iop
Publikováno v:
Journal of Clinical Oncology. 24:17155-17155
17155 Background: Platin (P) salts and Gemcitabine (G) are used for NSCLC. GP regimens frequently included G on day 1, 8 and 15; P on day 2; every 28 days. However, the third G dose often is omitted because of myelo-toxicity, with a consistent no res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::331c7fddd98f8123d21ed0c5420165fe
https://doi.org/10.1200/jco.2006.24.18_suppl.17155
https://doi.org/10.1200/jco.2006.24.18_suppl.17155